I believe its a bit more complex than that
Since the approval of exenatide for the treatment of type 2 diabetes by the Food and Drug Administration (FDA) in 2005, research on GLP-1 RAs has become a hot topic and new analogs are constantly being introduced to the market
Nathanson D, Ullman B, Lofstrom U, Hedman A, Frick M, Sjoholm A, Nystrom T: Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety
or very rapid heartbeat The most common side effects of RYBELSUS may include nausea, stomach (abdominal) pain, diarrhea, decreased appetite, vomiting, and constipation
At Omada, our members dont live in lab settings
Additionally, 100% of the participants taking either of the two higher doses (8 mg and 12 mg) lost at least 5% or more of their body weight